Community Member
3 years agoJust started Taxol - Herceptin & Perjeta 1X/WK - what are the general stats for responsiveness-effectiveness? My Onco said 50/50 w Stage 4 Inflammatory Breast Cancer.
Accepted Answer
Treatment response rates can vary significantly from person to person, and while general statistics provide helpful context, individual factors like overall health, tumor characteristics, and how the body responds to treatment play important roles in outcomes. The combination of Taxol with Herceptin and Perjeta is a well-established treatment approach for HER2+ breast cancer, and many patients in this community have experience with these medications and may be able to share insights about their treatment journeys.
3+ patients found this helpful
Community Member
5 months agoTreatment response rates can vary significantly from person to person, and while general statistics provide helpful context, individual factors like overall health, tumor characteristics, and how the body responds to treatment play important roles in outcomes. The combination of Taxol with Herceptin and Perjeta is a well-established treatment approach for HER2+ breast cancer, and many patients in this community have experience with these medications and may be able to share insights about their treatment journeys.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.